Furthermore, we demonstrate that PRMT2-depleted AML cells exhibit heightened activation of the NF-κB signaling pathway, leading to IL6 overexpression, and ultimately to an increased phosphorylation of the STAT3 protein. Here, PRMT2 is linked to acute myeloid leukemia.